BFLY vs OSUR
BFLY: Butterfly Network is transforming medical imaging with its semiconductor-based, handheld point-of-care ultrasound technology that brings clinical-grade scanning to the palm of the hand. OSUR: OrasuRe is a diagnostic company specializing in rapid point-of-care and self-test solutions for infectious diseases and rare conditions, with recent expansion into sickle cell screening through the BioMedomics acquisition.
Side-by-side fundamentals
| Metric | BFLY | OSUR | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $7.07 | $3.96 | |
| Market cap as of 2026-07-29 | $1.8B | $273M | |
| PEG as of 2026-07-29 | -29.22 | -0.03 | BFLY lower |
| Net margin as of 2026-07-29 | -73.7% | -66.4% | OSUR higher |
| Gross margin as of 2026-07-29 | +49.2% | +42.5% | BFLY higher |
| Operating margin as of 2026-07-29 | -79.5% | -68.6% | OSUR higher |
| ROE as of 2026-07-29 | -36.8% | -21.5% | OSUR higher |
| ROA as of 2026-07-29 | -25.6% | -18.2% | OSUR higher |
| Debt / equity as of 2026-07-29 | 0.00 | 0.00 | BFLY lower |
| Revenue growth (YoY) as of 2026-07-29 | +20.2% | -30.1% | BFLY higher |
| Revenue CAGR (3y) SEC XBRL | +10.0% | -33.3% | BFLY higher |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-07-29 | 2.11 | 1.04 | |
| 1-year return as of 2026-07-27 close | +258.9% | +17.9% | BFLY higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.